Lv1
30 积分 2024-08-20 加入
EP.07C.13 Aumolertinib as Adjuvant Therapy in Postoperative EGFR-Mutated Stage I NSCLC with Multiple High-Risk Factors
10个月前
已完结
Stage I Non-Small Cell Lung Cancer: Recurrence Patterns, Prognostic Factors and Survival
10个月前
已关闭
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
1年前
已完结